Assessment of cellular origin and EBV status in a PTLD after double cord blood transplantation

MeSH terms

• Adult
• Antibodies, Monoclonal / therapeutic use
• Antibodies, Monoclonal, Murine-Derived
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Combined Modality Therapy
• Cord Blood Stem Cell Transplantation / adverse effects*
• Diagnosis, Differential
• Epstein-Barr Virus Infections / diagnosis*
• Epstein-Barr Virus Infections / transmission
• Female
• Herpesvirus 4, Human / isolation & purification
• Herpesvirus 4, Human / physiology
• Humans
• Immunosuppressive Agents / adverse effects
• Infant, Newborn
• Lymphoma, Non-Hodgkin / drug therapy
• Lymphoma, Non-Hodgkin / surgery*
• Lymphoproliferative Disorders / drug therapy
• Lymphoproliferative Disorders / etiology*
• Lymphoproliferative Disorders / virology
• Male
• Myelodysplastic Syndromes / chemically induced
• Myelodysplastic Syndromes / surgery*
• Peripheral Blood Stem Cell Transplantation*
• Rituximab
• Transplantation, Autologous / adverse effects*
• Transplantation, Homologous / adverse effects*
• Virus Activation*